The relatively ineffective hydrolysis of FDGlcU in tumors treated with E. coli (lux/βG) suggested that the chemical probe delivered via the tumor blood supply may not effectively contact beta-glucuronidase in the tumor. The gene discussed is GUSB; the disease is neoplasm.